These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 29355887
1. Accuracy of fetal fibronectin for assessing preterm birth risk in asymptomatic pregnant women: a systematic review and meta-analysis. Dos Santos F, Daru J, Rogozińska E, Cooper NAM. Acta Obstet Gynecol Scand; 2018 Jun; 97(6):657-667. PubMed ID: 29355887 [Abstract] [Full Text] [Related]
2. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis. Deshpande SN, van Asselt AD, Tomini F, Armstrong N, Allen A, Noake C, Khan K, Severens JL, Kleijnen J, Westwood ME. Health Technol Assess; 2013 Sep; 17(40):1-138. PubMed ID: 24060096 [Abstract] [Full Text] [Related]
3. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis. Melchor JC, Khalil A, Wing D, Schleussner E, Surbek D. Ultrasound Obstet Gynecol; 2018 Oct; 52(4):442-451. PubMed ID: 29920825 [Abstract] [Full Text] [Related]
4. Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women. Jun SY, Lee JY, Kim HM, Kim MJ, Cha HH, Seong WJ. BMC Pregnancy Childbirth; 2019 Jul 11; 19(1):241. PubMed ID: 31296172 [Abstract] [Full Text] [Related]
5. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation. Varley-Campbell J, Mújica-Mota R, Coelho H, Ocean N, Barnish M, Packman D, Dodman S, Cooper C, Snowsill T, Kay T, Liversedge N, Parr M, Knight L, Hyde C, Shennan A, Hoyle M. Health Technol Assess; 2019 Mar 11; 23(13):1-226. PubMed ID: 30917097 [Abstract] [Full Text] [Related]
6. Predictive value of quantitative fetal fibronectin for spontaneous preterm birth in asymptomatic pregnancies: a systematic literature review and meta-analysis. Ruma MS, Betts M, Dodman S, Neupane B. J Matern Fetal Neonatal Med; 2023 Dec 11; 36(2):2279923. PubMed ID: 37953268 [Abstract] [Full Text] [Related]
7. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study. Melchor JC, Navas H, Marcos M, Iza A, De Diego M, Rando D, Melchor I, Burgos J. Ultrasound Obstet Gynecol; 2018 May 11; 51(5):644-649. PubMed ID: 28850753 [Abstract] [Full Text] [Related]
8. The fetal fibronectin test is superior to cervical length measurement in predicting preterm birth in twin pregnancies: a retrospective observational study. Holzer I, Koch-Trappel M, Leitich H, Meyer EL, Farr A, Helmer H. Eur J Obstet Gynecol Reprod Biol; 2020 Apr 11; 247():22-25. PubMed ID: 32058186 [Abstract] [Full Text] [Related]
9. The short-term prediction of preterm birth: a systematic review and diagnostic metaanalysis. Boots AB, Sanchez-Ramos L, Bowers DM, Kaunitz AM, Zamora J, Schlattmann P. Am J Obstet Gynecol; 2014 Jan 11; 210(1):54.e1-54.e10. PubMed ID: 24021995 [Abstract] [Full Text] [Related]
10. Comparison of rapid bedside tests for phosphorylated insulin-like growth factor-binding protein 1 and fetal fibronectin to predict preterm birth. Tripathi R, Tyagi S, Mala YM, Singh N, Pandey NB, Yadav P. Int J Gynaecol Obstet; 2016 Oct 11; 135(1):47-50. PubMed ID: 27388033 [Abstract] [Full Text] [Related]
11. The diagnostic value of fetal fibronectin testing in clinical practice. Cornelissen LGH, van Oostrum NHM, van der Woude DAA, Rolf C, Porath MM, Oei SG, van Laar JOEH. J Obstet Gynaecol Res; 2020 Mar 11; 46(3):405-412. PubMed ID: 31955485 [Abstract] [Full Text] [Related]
12. Prediction of spontaneous preterm birth in asymptomatic twin pregnancies with the use of combined fetal fibronectin and cervical length. Fox NS, Saltzman DH, Klauser CK, Peress D, Gutierrez CV, Rebarber A. Am J Obstet Gynecol; 2009 Sep 11; 201(3):313.e1-5. PubMed ID: 19733285 [Abstract] [Full Text] [Related]
13. The significance of a positive fetal fibronectin in the setting of a normal cervical length in twin pregnancies. Fox NS, Rebarber A, Roman AS, Klauser CK, Saltzman DH. Am J Perinatol; 2012 Apr 11; 29(4):267-72. PubMed ID: 21818730 [Abstract] [Full Text] [Related]
14. Vaginal fetal fibronectin as a predictor of spontaneous preterm delivery in triplet gestations. Roman AS, Pessel C, Fox N, Klauser CK, Saltzman D, Rebarber A. J Matern Fetal Neonatal Med; 2012 Oct 11; 25(10):1921-3. PubMed ID: 22489752 [Abstract] [Full Text] [Related]
15. Quantitative fetal fibronectin screening in asymptomatic high-risk patients and the spectrum of risk for recurrent preterm delivery. Kurtzman J, Chandiramani M, Briley A, Poston L, Das A, Shennan A. Am J Obstet Gynecol; 2009 Mar 11; 200(3):263.e1-6. PubMed ID: 19254585 [Abstract] [Full Text] [Related]
16. Accuracy of fetal fibronectin for the prediction of preterm birth in symptomatic twin pregnancies: a pilot study. Fuchs F, Lefevre C, Senat MV, Fernandez H. Sci Rep; 2018 Feb 01; 8(1):2160. PubMed ID: 29391455 [Abstract] [Full Text] [Related]
17. Combined fetal fibronectin and cervical length and spontaneous preterm birth in asymptomatic triplet pregnancies. Fox NS, Rebarber A, Roman AS, Klauser CK, Peress D, Saltzman DH. J Matern Fetal Neonatal Med; 2012 Nov 01; 25(11):2308-11. PubMed ID: 22563765 [Abstract] [Full Text] [Related]